Trump gets the benefit of friendship: The French pharmaceutical company says the vaccine will go to the US first

Paris, Ta. 14 May 2020, Thursday

French pharmaceutical company Sanofi has announced that it will be the first to deliver its first vaccine to the United States. A few weeks ago, a US newspaper revealed that President Trump owns shares in the company. Trump has invested in the Sanofi company and this is probably why Sanofi has announced that it will be the first to give its corona vaccine to the United States. According to Paul Hudson, CEO of Sanofi, the United States has invested heavily in the company and therefore has the right to the first corona vaccine to be manufactured by the company.

Paul Hudson warned that Europe was lagging behind in this matter. The situation in Europe is very serious. The U.S. invested heavily in Sanofi in February and pre-ordered the company's vaccine. Sanofi is one of the largest companies working for the corona vaccine in the world, and at the request of the US, Sanofi has struck a deal with its rival GlaxoSmithKline. According to the deal, the two companies will be able to make 600 million vaccines a year together.

The Donald Trump administration is currently running Operation Warp Speed, under which the United States is providing a variety of assistance to a number of drug companies, including funding for corona vaccine research. The US Biomedical Advanced Research and Development Authority (BARDA) has given Sanofi 30 30 million, or more than Rs 226 crore, to work on the corona vaccine.

The relationship between Barda and Sanofi is very old. In December last year, the United States provided ફ 226 million, or more than Rs 1,705 crore, to Sanofi to develop an influenza vaccine. US President Trump is taking more interest in the malaria drug hydroxychloroquine, which also includes his personal advantage. If hydroxychloroquine is approved for the treatment of corona worldwide, companies that manufacture this drug will benefit greatly. Trump owns shares in one such company and has close ties to its top executives.

Trump owns shares in the Sanofi Company, which sells the hydroxychloroquine drug under the brand name Placanil. Many people in India fall victim to malaria every year in which the drug hydroxychloroquine proves to be an elixir so that it is also mass-produced in India. This drug is slightly different from the anti-malaria drug chloroquine. The drug, in tablet form, is used in autoimmune diseases, including arthritis, and has been shown to be useful against corona.

This drug has a special effect on SARS-COV-2 in particular. This is the same virus that causes covid-2 and this is why corona patients are being given hydroxychloroquine tablets.